Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) EBIT: 2010-2018

Historic EBIT for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to -$26.3 million.

  • EyePoint Pharmaceuticals' EBIT fell 125.67% to -$13.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$33.8 million, marking a year-over-year decrease of 94.42%. This contributed to the annual value of -$26.3 million for FY2018, which is 41.44% down from last year.
  • As of FY2018, EyePoint Pharmaceuticals' EBIT stood at -$26.3 million, which was down 41.44% from -$18.6 million recorded in FY2017.
  • EyePoint Pharmaceuticals' EBIT's 5-year high stood at $6.4 million during FY2015, with a 5-year trough of -$26.3 million in FY2018.
  • Moreover, its 3-year median value for EBIT was -$21.8 million (2016), whereas its average is -$22.2 million.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 147.60% in 2015, then plummeted by 439.11% in 2016.
  • Over the past 5 years, EyePoint Pharmaceuticals' EBIT (Yearly) stood at -$13.5 million in 2014, then surged by 147.60% to $6.4 million in 2015, then slumped by 439.11% to -$21.8 million in 2016, then rose by 14.69% to -$18.6 million in 2017, then plummeted by 41.44% to -$26.3 million in 2018.